Italian Register for the Study of Complicated Intra-Abdominal Infections
IRCA
1 other identifier
observational
1,000
1 country
1
Brief Summary
The study will identify the epidemiological and treatment profiles of acute peritonitis in Italy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2018
CompletedFirst Posted
Study publicly available on registry
September 19, 2018
CompletedStudy Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedSeptember 19, 2018
August 1, 2018
1 year
September 17, 2018
September 18, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Mortality rates linked to different sources of infection
12 months
Mortality rates linked to different bacteria causing infection
12 months
Interventions
All consecutively hospitalized adult patients (older than 18 years of age) undergoing surgery, interventional drainage or conservative treatment, with diagnosis of cIAIs (defined as abdominal infections originating in an organ cavity, extending into the peritoneal space, and forming an abscess or peritonitis, will be included in the study.
Eligibility Criteria
All patients with complicated intra-abdominal infections
You may qualify if:
- All consecutively hospitalized adult patients (older than 18 years of age) undergoing surgery, interventional drainage or conservative treatment, with diagnosis of cIAIs (defined as abdominal infections originating in an organ cavity, extending into the peritoneal space, and forming an abscess or peritonitis)
You may not qualify if:
- Patients younger than 16 years-old, patients with pancreatitis or primary peritonitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
WSES
Bologna, 40139, Italy
Biospecimen
Microbiological samples
Study Officials
- PRINCIPAL INVESTIGATOR
Massimo Sartelli, MD
WSES
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
September 17, 2018
First Posted
September 19, 2018
Study Start
January 1, 2019
Primary Completion
January 1, 2020
Study Completion
April 1, 2020
Last Updated
September 19, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share